No-Reflow Phenomenon in Patients with ST-Elevation Acute Myocardial Infarction, Treated with Primary Percutaneous Coronary Intervention: A Study of Predictive Factors

No-Reflow Phenomenon in Patients with ST-Elevation Acute Myocardial Infarction, Treated with Primary Percutaneous Coronary Intervention: A Study of Predictive Factors

Introduction: No-reflow phenomenon in coronary vessels, manifested in some patients with reperfused acute myocardial infarction (MI), is associated with poor clinical and functional outcomes. Therefore, evaluation of predisposing risk factors can be helpful in risk assessment and identification of...

Full description

Bibliographic Details
Main Authors:	Seyed Hashem Danesh Sani, Ali Eshraghi, Bahram Shahri, Mohamad Vejdanparast
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2014-11-01
Series:	Journal of Cardio-Thoracic Medicine
Subjects:	Myocardial Infarction,No Reflow Phenomenon Percutaneous Coronary Intervention
Online Access:	http://jctm.mums.ac.ir/pdf_3491_d95ceea34398c8b49df2eb047382f461.html

Similar Items

Pharmacological correction of no-reflow phenomenon in myocardial infarction treatment
by: T. Yu. Mamonova, et al.
Published: (2009-04-01)

Correlates of the “No-Reflow” or “Slow-Flow” Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention
by: Mohammad Alidoosti, et al.
Published: (2018-07-01)

Comparison of no-reflow phenomenon after percutaneous coronary intervention for acute myocardial infarction between smokers and nonsmokers
by: Hassan Shemirani, et al.
Published: (2014-01-01)

«No-reflow» phenomenon and risk factors associated with its development after primary percutaneous coronary interventions in patients with ST elevation myocardial infarction
by: V.І. Tseluyko, et al.
Published: (2018-09-01)

Evaluation of the clinical and procedural predictive factors of no-reflow phenomenon following primary percutaneous coronary intervention
by: Seifollah Abdi, et al.
Published: (2015-01-01)

Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis
by: Xiaowei Niu, et al.
Published: (2018-01-01)

NO-REFLOW PHENOMENON IN THE PRACTICE OF AN ENDOVASCULAR SURGEON
by: A. M. Gerasimov, et al.
Published: (2016-06-01)

Clinical, Laboratory, and Procedural Predictors of No-Reflow in Patients Undergoing Primary Percutaneous Coronary Intervention
by: Maryam Shakiba, et al.
Published: (2020-04-01)

PRIMARY ANGIOPLASTICS AND PHARMACOINVASIVE REPERFUSION IN MYOCARDIAL INFARCTION: IMPACT ON CLINICAL OUTCOMES AND NO-REFLOW PHENOMENON
by: E. V. Vyshlov, et al.
Published: (2015-02-01)

Effectiveness of deferred coronary artery stenting in the prevention of no-reflow in patients with acute ST-segment elevation myocardial infarction
by: A. V. Azarov, et al.
Published: (2021-03-01)

Association between the No-Reflow Phenomenon and Soluble CD40 Ligand Level in Patients with Acute ST-Segment Elevation Myocardial Infarction
by: Mustafa Begenc Tascanov, et al.
Published: (2019-07-01)

The ‘MAP strategy’ (Maximum aspiration of atherothrombus and adjunctive glycoprotein IIb/IIIa inhibitor utilization combined with prolonged inflation of balloon/stent) for preventing no-reflow in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: A retrospective analysis of seventy-one cases
by: Anil Potdar, et al.
Published: (2015-12-01)

Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion
by: X.J. Zhao, et al.
Published: (2014-03-01)

Machine learning to predict no reflow and in-hospital mortality in patients with ST-segment elevation myocardial infarction that underwent primary percutaneous coronary intervention
by: Deng, L., et al.
Published: (2022)

New CHA2DS2-VASc-HSF score predicts the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
by: Qin-Yao Zhang, et al.
Published: (2020-07-01)

The relation between platelet/lymphocyte ratio and the occurrence of no reflow in patients with ST-segment elevation myocardial infarction managed by primary percutaneous coronary intervention
by: Ahmed Mohamed El Missiri, et al.
Published: (2021-01-01)

Factors associated with the no-reflow phenomenon following percutaneous intervention of saphenous vein coronary bypass grafts
by: Mohammad Hashemi-Jazi, et al.
Published: (2017-10-01)

Novel predictors and adverse long-term outcomes of No-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Hesham Refaat, et al.
Published: (2021-01-01)

Effect of no-reflow/reflow on P-wave time indexes in patients with acute myocardial infarction undergoing percutaneous coronary intervention
by: Ahmet Karakurt, et al.
Published: (2020-01-01)

Incidence and Associated Factors of No-reflow Phenomenon in STEMI Patients Treated with Primary PCI
by: Abdolatif Amini, et al.
Published: (2010-09-01)

MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY IN ACUTE ST ELEVATION MYOCARDIAL INFARCTION
by: Martin Tretjak
Published: (2004-07-01)

Safety and Efficacy of Intracoronary Vasodilators in the Treatment of No-Reflow after Primary Percutaneous Intervention in Patients with Acute ST-Elevation Myocardial Infarction: A Literature Review
by: Mostafa Dastani, et al.
Published: (2016-04-01)

The value of pre admission Thrombolysis in Myocardial Infarction (TIMI) Risk Index (TRI) in the prediction of no-reflow phenomenon after primary percutaneous coronary intervention in patients presented with ST Segment Elevation Myocardial Infarction (STEMI)
by: Metwally H Elemary, et al.
Published: (2018-01-01)

Relation of hemoglobin level to no-reflow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention
by: Barış Yaylak, et al.
Published: (2018-12-01)

Association between Endothelial Nitric Oxide Synthase Gene Polymorphism (Glu298Asp) and Coronary No-Reflow Phenomenon in Acute Myocardial Infarction
by: Ahmet Arif Yalcin, et al.
Published: (2019-10-01)

The Relationship Between The Level Of Serum Uric Acid And No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention İn Patients With St Segment Elevated Myocardial Infarction
by: İsmail ERDEN, Emine Çakcak ERDEN, Serhat Bahadır SÖZEN, Osman Kayapınar, Sabri Onur ÇAĞLAR, Cengiz BAŞAR
Published: (2010-11-01)

High admission levels of γ-glutamyltransferase predict poor myocardial perfusion after primary percutaneous intervention
by: Uygar Cagdas Yuksel, et al.
Published: (2011-01-01)

No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
by: Sanjiv Gupta, et al.
Published: (2016-07-01)

Aspiration Thrombectomy in Patients with Acute Myocardial Infarction—5-Year Analysis Based on a Large National Registry (ORPKI)
by: Rafał Januszek, et al.
Published: (2020-11-01)

Effects of no-reflow phenomenon on ventricular systolic synchrony in patients with acute anterior myocardial infarction after percutaneous coronary intervention
by: Wang L, et al.
Published: (2016-06-01)

Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials
by: Xu L, et al.
Published: (2019-04-01)

Effect of GP IIb/IIIa inhibitor duration on the clinical prognosis of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction with no-/slow-reflow phenomenon
by: Xiangming Hu, et al.
Published: (2021-11-01)

Platelet-To-Lymphocyte Ratio as a Predictor of No-Reflow after Primary Percutaneous Coronary Intervention in Patients with ST Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis
by: Amin Saberi, et al.
Published: (2019-06-01)

Effect of chronic pretreatment with beta-blockers on no-reflow phenomenon in diabetic patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Ali Mohammed Kareem Al-Jabari, et al.
Published: (2017-09-01)

Development of a risk score for no-reflow phenomenon after percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction
by: I. S. Bessonov, et al.
Published: (2020-11-01)

No-Reflow after PPCI—A Predictor of Short-Term Outcomes in STEMI Patients
by: Larisa Renata Pantea-Roșan, et al.
Published: (2020-09-01)

Microvascular obstruction due to thrombosis and fibrin deposition in myocardial infarction
by: Emre Aslanger, et al.
Published: (2016-02-01)

Platelet-Lymphocyte ratio is a predictor for the development of no-reflow phenomenon in patients with ST-segment elevation myocardial infarction after thrombus aspiration
by: Emren, S.V, et al.
Published: (2021)

The relationship between visible thrombus aspiration material with no-reflow and in-hospital mortality ratio in patients with anterior ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
by: Taner Şeker, et al.
Published: (2019-03-01)

Comparison of RCHA2DS2-VASc score and CHA2DS2-VASc score prediction of no-reflow phenomenon in patients with ST-segment elevation myocardial infarction
by: Çağrı Zorlu, et al.
Published: (2020-10-01)